Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

13 Jan 2025 07:00

RNS Number : 9743S
Polar Capital Holdings PLC
13 January 2025
 

13 January 2025 Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM") and performance fees earned for the financial year to 31 March 2025.

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 December 2024, AuM was £23.8bn compared to £21.9bn at the end of March 2024, an increase of 9% over the period. During the nine-month period, AuM increased by net inflows of £0.2bn, a £1.8bn increase related to market movement and fund performance and partially offset by fund closures of £0.1bn.

 

 

AuM movement in nine months to 31 December 2024

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated mandates

(£m)

Total

(£m)

AuM at 1 April 2024

15,988

5,088

816

21,892

Net flows

537

(131)

(194)

212

Fund closure1

(100)

-

-

(100)

Market movement

and performance

1,093

692

3

1,788

Total AuM at

31 December 2024

17,518

5,649

625

23,792

1 Return of funds to investors on closure of the Forager fund in October 2024.

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fee profits (after the deduction of staff interests) earned in the first nine months of the Group's financial year.

 

Performance fee profit

net of staff allocations

Nine months to

31 Dec 23

Year to

31 Mar 24

(year-end)

Nine months to

31 Dec 24*

Net performance fee profit

£9.6m

£9.6m

£8.3m*

\* The figures to December 2024 are enhanced by what is expected to be approximately £0.8m of net deferment adjustments.

 

Gavin Rochussen, Chief Executive, commented:

 

"Despite a late December 2024 sell off in global equity markets, and net outflows during the final calendar quarter, AuM at the end of the nine-month period increased to £23.8bn from £22.7bn at the end of the previous quarter and £21.9bn at the end of March 2024.

 

"During the quarter we benefited from continued net inflows into the Emerging Market Stars funds and related managed accounts of £240m and the Artificial Intelligence Fund of £14m. This was offset by several other funds experiencing net outflows including the European Opportunities Fund and related managed accounts (£158m), Global Technology Fund (£123m) and UK Value Fund (£92m) as well as the planned closure of the Forager European Long/Short Fund (£100m).

 

"Net flows have improved year-on-year with net outflows, including a fund closure of £100m, during the quarter of £360m compared to net outflows in the comparable quarter in the prior year of £1.1bn.

 

"Net outflows during the quarter were primarily concentrated in October, mirroring the broader UK funds industry, which experienced its third worst month on record ahead of the Chancellor's Autumn Budget. Including the impact of a fund closure, net outflows for the month of October totalled £301m. Net outflows in December were £76m. November saw net inflows of £17m.

 

"Performance fee profits, net of staff allocations, amounted to £8.3m compared to £0.7m at the end of September 2024, and £9.6m in the prior year. While five funds earned a performance fee, most of the amount related to one fund.

 

"Long term performance remains strong with 89% of UCITs AuM outperforming respective benchmarks since inception.

 

"We remain confident that with our diverse range of differentiated, active specialist fund strategies we are well-positioned to perform for our clients and shareholders over the long term."

 

 

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)

Samir Ayub (Chief Financial Officer)

 

+44 (0)20 7227 2700

Deutsche Numis - Nomad and Joint Broker

Giles Rolls

Charles Farquhar

 

+44 (0)20 7260 1000

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Oliver Jackson

 

 

+44 (0)20 3597 8680

Camarco - PR

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

 

+44 (0)20 3757 4980

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAXFEFFXSEFA
Date   Source Headline
4th Feb 20199:43 amRNSBlock listing Interim Review
1st Feb 201911:41 amRNSTotal Voting Rights
29th Jan 20194:41 pmRNSSecond Price Monitoring Extn
29th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20195:45 pmRNSIssue of Equity
28th Jan 20195:30 pmRNSDirector/PDMR Shareholding
10th Jan 201910:19 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSAUM Update
2nd Jan 20199:49 amRNSTotal Voting Rights
12th Dec 20184:00 pmRNSIssue of Equity
27th Nov 20184:40 pmRNSSecond Price Monitoring Extn
27th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.